簡介

本頁面提供了有關 Mehdi Gasmi 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Mehdi Gasmi已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:ADVM / Adverum Biotechnologies, Inc. Director 40,000
如何解讀這些圖表

以下圖表顯示了在Mehdi Gasmi進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

歷史內部人交易

該表格顯示了由 Mehdi Gasmi 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2021-05-14 2021-05-12 4 ADVM Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
A - Award 40,000 40,000
2020-07-22 2020-07-20 4 ADVM Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
M - Exercise -5,000 78,000 -6.02
2020-07-22 2020-07-20 4 ADVM Adverum Biotechnologies, Inc.
Common Stock
S - Sale X -5,000 274,442 -1.79 17.60 -87,978 4,828,972
2020-07-22 2020-07-20 4 ADVM Adverum Biotechnologies, Inc.
Common Stock
M - Exercise 5,000 279,442 1.82 4.80 24,000 1,341,322
2020-06-25 2020-06-23 4 ADVM Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
A - Award 30,000 30,000
2020-06-23 2020-06-22 4 ADVM Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
M - Exercise -23,605 83,000 -22.14
2020-06-23 2020-06-22 4 ADVM Adverum Biotechnologies, Inc.
Common Stock
S - Sale X -23,605 274,442 -7.92 25.06 -591,617 6,878,395
2020-06-23 2020-06-22 4 ADVM Adverum Biotechnologies, Inc.
Common Stock
M - Exercise 23,605 298,047 8.60 4.80 113,304 1,430,626
2020-06-18 2020-06-18 4 ADVM Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
M - Exercise -11,127 106,605 -9.45
2020-06-18 2020-06-18 4 ADVM Adverum Biotechnologies, Inc.
Common Stock
S - Sale X -11,127 274,442 -3.90 25.01 -278,329 6,864,837
2020-06-18 2020-06-18 4 ADVM Adverum Biotechnologies, Inc.
Common Stock
M - Exercise 11,127 285,569 4.05 4.80 53,410 1,370,731
2020-06-18 2020-06-17 4 ADVM Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
M - Exercise -268 117,732 -0.23
2020-06-18 2020-06-17 4 ADVM Adverum Biotechnologies, Inc.
Common Stock
S - Sale X -268 274,442 -0.10 25.01 -6,703 6,863,822
2020-06-18 2020-06-17 4 ADVM Adverum Biotechnologies, Inc.
Common Stock
M - Exercise 268 274,710 0.10 4.80 1,286 1,318,608
2020-06-17 2020-06-15 4 ADVM Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
M - Exercise -10,000 118,000 -7.81
2020-06-17 2020-06-15 4 ADVM Adverum Biotechnologies, Inc.
Common Stock
S - Sale X -159 274,442 -0.06 23.59 -3,751 6,474,718
2020-06-17 2020-06-15 4 ADVM Adverum Biotechnologies, Inc.
Common Stock
S - Sale X -3,425 274,601 -1.23 23.00 -78,787 6,316,757
2020-06-17 2020-06-15 4 ADVM Adverum Biotechnologies, Inc.
Common Stock
S - Sale X -1,416 278,026 -0.51 21.93 -31,047 6,095,970
2020-06-17 2020-06-15 4 ADVM Adverum Biotechnologies, Inc.
Common Stock
S - Sale X -5,000 279,442 -1.76 21.01 -105,042 5,870,629
2020-06-17 2020-06-15 4 ADVM Adverum Biotechnologies, Inc.
Common Stock
M - Exercise 10,000 284,442 3.64 4.80 48,000 1,365,322
2020-05-22 2020-05-21 4 ADVM Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
M - Exercise -3,599 128,000 -2.73
2020-05-22 2020-05-21 4 ADVM Adverum Biotechnologies, Inc.
Common Stock
S - Sale X 3,599 274,442 1.33 20.02 72,048 5,494,027
2020-05-22 2020-05-21 4 ADVM Adverum Biotechnologies, Inc.
Common Stock
M - Exercise 3,599 278,041 1.31 4.80 17,275 1,334,597
2020-05-22 2020-05-20 4 ADVM Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
M - Exercise -1,401 131,599 -1.05
2020-05-22 2020-05-20 4 ADVM Adverum Biotechnologies, Inc.
Common Stock
S - Sale X -1,401 274,442 -0.51 20.01 -28,030 5,490,789
2020-05-22 2020-05-20 4 ADVM Adverum Biotechnologies, Inc.
Common Stock
M - Exercise 1,401 275,843 0.51 4.80 6,725 1,324,046
2020-05-20 2020-05-18 4 ADVM Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
M - Exercise -5,000 133,000 -3.62
2020-05-20 2020-05-18 4 ADVM Adverum Biotechnologies, Inc.
Common Stock
S - Sale X -300 274,442 -0.11 19.03 -5,709 5,222,631
2020-05-20 2020-05-18 4 ADVM Adverum Biotechnologies, Inc.
Common Stock
S - Sale X -4,700 274,742 -1.68 18.11 -85,124 4,975,990
2020-05-20 2020-05-18 4 ADVM Adverum Biotechnologies, Inc.
Common Stock
M - Exercise 5,000 279,442 1.82 4.80 24,000 1,341,322
2020-05-20 2020-05-06 4 ADVM Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
M - Exercise -25,000 138,000 -15.34
2020-05-20 2020-05-06 4 ADVM Adverum Biotechnologies, Inc.
Common Stock
S - Sale X -25,000 274,442 -8.35 20.03 -500,668 5,496,168
2020-05-20 2020-05-06 4 ADVM Adverum Biotechnologies, Inc.
Common Stock
M - Exercise 25,000 299,442 9.11 4.80 120,000 1,437,322
2020-05-20 2020-05-05 4 ADVM Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
M - Exercise -10,000 163,000 -5.78
2020-05-20 2020-05-05 4 ADVM Adverum Biotechnologies, Inc.
Common Stock
S - Sale X -10,000 274,442 -3.52 16.26 -162,573 4,461,686
2020-05-20 2020-05-05 4 ADVM Adverum Biotechnologies, Inc.
Common Stock
M - Exercise 10,000 284,442 3.64 4.80 48,000 1,365,322
2020-05-20 2020-02-12 4/A ADVM Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
M - Exercise -10,000 178,000 -5.32
2020-05-20 2020-02-12 4/A ADVM Adverum Biotechnologies, Inc.
Common Stock
S - Sale X -10,000 274,442 -3.52 15.07 -150,690 4,135,566
2020-05-20 2020-02-12 4/A ADVM Adverum Biotechnologies, Inc.
Common Stock
M - Exercise 10,000 284,442 3.64 4.80 48,000 1,365,322
2020-05-20 2020-02-12 4/A ADVM Adverum Biotechnologies, Inc.
Common Stock
F - Taxes -15,494 274,442 -5.34 15.05 -233,185 4,130,352
2020-05-20 2020-02-12 4/A ADVM Adverum Biotechnologies, Inc.
Common Stock
F - Taxes -31,482 289,936 -9.79 11.33 -356,691 3,284,975
2020-05-20 2020-01-15 4/A ADVM Adverum Biotechnologies, Inc.
Common Stock
A - Award 88,496 321,418 37.99
2020-02-20 2020-02-18 4 ADVM Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
M - Exercise 5,000 173,000 2.98
2020-02-20 2020-02-18 4 ADVM Adverum Biotechnologies, Inc.
Common Stock
S - Sale X -5,000 258,979 -1.89 16.23 -81,156 4,203,540
2020-02-20 2020-02-18 4 ADVM Adverum Biotechnologies, Inc.
Common Stock
M - Exercise 5,000 263,979 1.93 4.80 24,000 1,267,099
2020-02-14 2020-02-12 4 ADVM Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
M - Exercise -10,000 178,000 -5.32
2020-02-14 2020-02-12 4 ADVM Adverum Biotechnologies, Inc.
Common Stock
S - Sale X -10,000 258,979 -3.72 15.07 -150,690 3,902,555
2020-02-14 2020-02-12 4 ADVM Adverum Biotechnologies, Inc.
Common Stock
M - Exercise 10,000 268,979 3.86 4.80 48,000 1,291,099
2020-02-14 2020-02-12 4 ADVM Adverum Biotechnologies, Inc.
Common Stock
F - Taxes -15,494 258,979 -5.64 15.05 -233,185 3,897,634
2020-02-14 2020-02-12 4 ADVM Adverum Biotechnologies, Inc.
Common Stock
F - Taxes -31,451 289,967 -9.79 11.33 -356,340 3,285,326
2020-02-14 2020-01-15 4 ADVM Adverum Biotechnologies, Inc.
Common Stock
A - Award 88,496 321,418 37.99
2020-02-14 2020-02-09 4/A ADVM Adverum Biotechnologies, Inc.
Common Stock
F - Taxes -15,494 274,473 -5.34 10.24 -158,659 2,810,604
2020-02-10 2019-04-21 4 ADVM Adverum Biotechnologies, Inc.
Common Stock
F - Taxes -589 321,418 -0.18 5.98 -3,522 1,922,080
2020-02-10 2019-02-12 4 ADVM Adverum Biotechnologies, Inc.
Common Stock
F - Taxes -10,652 322,007 -3.20 3.55 -37,815 1,143,125
2020-02-10 2019-02-09 4 ADVM Adverum Biotechnologies, Inc.
Common Stock
F - Taxes -12,599 332,659 -3.65 3.33 -41,955 1,107,754
2020-02-10 2018-04-21 4 ADVM Adverum Biotechnologies, Inc.
Common Stock
F - Taxes -605 247,762 -0.24 6.30 -3,812 1,560,901
2020-02-10 2018-02-12 4 ADVM Adverum Biotechnologies, Inc.
Common Stock
F - Taxes -10,806 248,367 -4.17 6.85 -74,021 1,701,314
2020-02-10 2018-02-09 4 ADVM Adverum Biotechnologies, Inc.
Common Stock
F - Taxes -11,433 259,173 -4.22 7.05 -80,603 1,827,170
2020-02-10 2017-08-21 4 ADVM Adverum Biotechnologies, Inc.
Common Stock
F - Taxes -5,479 270,606 -1.98 2.50 -13,698 676,515
2020-02-10 2017-04-21 4 ADVM Adverum Biotechnologies, Inc.
Common Stock
F - Taxes -657 276,085 -0.24 2.70 -1,774 745,430
2020-02-10 2017-02-12 4 ADVM Adverum Biotechnologies, Inc.
Common Stock
F - Taxes -12,793 276,742 -4.42 3.00 -38,379 830,226
2020-02-10 2020-02-09 4 ADVM Adverum Biotechnologies, Inc.
Common Stock
F - Taxes -11,551 309,867 -3.59 10.24 -118,282 3,173,038
2020-02-10 2018-06-15 4/A ADVM Adverum Biotechnologies, Inc.
Common Stock
A - Award 88,496 345,258 34.47
2019-02-19 2019-02-14 4 ADVM Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
A - Award 225,000 225,000
2018-06-18 2018-06-15 4 ADVM Adverum Biotechnologies, Inc.
Common Stock
A - Award 88,496 387,031 29.64
2018-02-20 2018-02-15 4 ADVM Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
A - Award 160,000 160,000
2017-02-13 2017-02-09 4 ADVM Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
A - Award 181,000 181,000
2017-02-13 2017-02-09 4 ADVM Adverum Biotechnologies, Inc.
Common Stock
A - Award 125,000 289,535 75.97
2016-02-17 2016-02-12 4 AAVL Avalanche Biotechnologies, Inc.
Stock Option (Right to Buy)
A - Award 188,000 188,000
2016-02-17 2016-02-12 4 AAVL Avalanche Biotechnologies, Inc.
Common Stock
A - Award 125,000 161,803 339.65
2015-08-25 2015-08-21 4 AAVL Avalanche Biotechnologies, Inc.
Common Stock
A - Award 29,160 36,160 416.57
2015-06-17 2015-06-15 4 [AAVL] Avalanche Biotechnologies, Inc.
Stock Option (Right to Buy)
M - Exercise X -500 95,000 -0.52
2015-06-17 2015-06-15 4 [AAVL] Avalanche Biotechnologies, Inc.
Common Stock
S - Sale X -500 7,000 -6.67 39.86 -19,931 279,034
2015-06-17 2015-06-15 4 [AAVL] Avalanche Biotechnologies, Inc.
Common Stock
M - Exercise X 500 7,500 7.14 2.75 1,375 20,625
2015-06-10 2015-06-08 4 [AAVL] Avalanche Biotechnologies, Inc.
Stock Option (Right to Buy)
M - Exercise X -500 95,500 -0.52
2015-06-10 2015-06-08 4 [AAVL] Avalanche Biotechnologies, Inc.
Common Stock
S - Sale X -82 7,000 -1.16 39.88 -3,270 279,178
2015-06-10 2015-06-08 4 [AAVL] Avalanche Biotechnologies, Inc.
Common Stock
S - Sale X -183 7,082 -2.52 38.95 -7,128 275,847
2015-06-10 2015-06-08 4 [AAVL] Avalanche Biotechnologies, Inc.
Common Stock
S - Sale X -235 7,265 -3.13 37.97 -8,923 275,840
2015-06-10 2015-06-08 4 [AAVL] Avalanche Biotechnologies, Inc.
Common Stock
M - Exercise X 500 7,500 7.14 2.75 1,375 20,625
2015-06-05 2015-05-28 4/A AAVL Avalanche Biotechnologies, Inc.
Stock Option (Right to Buy)
M - Exercise X -500 96,000 -0.52
2015-06-05 2015-05-28 4/A AAVL Avalanche Biotechnologies, Inc.
Common Stock
S - Sale X -500 7,000 -6.67 38.02 -19,009 266,126
2015-06-05 2015-05-28 4/A AAVL Avalanche Biotechnologies, Inc.
Common Stock
M - Exercise X 500 7,500 7.14 2.75 1,375 20,625
2015-05-29 2015-05-28 4 [AAVL] Avalanche Biotechnologies, Inc.
Stock Option (Right to Buy)
M - Exercise X -500 96,000 -0.52
2015-05-29 2015-05-28 4 [AAVL] Avalanche Biotechnologies, Inc.
Common Stock
S - Sale X -500 7,000 -6.67 38.02 -19,009 266,126
2015-05-29 2015-05-28 4 [AAVL] Avalanche Biotechnologies, Inc.
Common Stock
M - Exercise X 500 7,500 7.14 2.75 1,375 20,625
2015-05-22 2015-05-21 4 AAVL Avalanche Biotechnologies, Inc.
Stock Option (Right to Buy)
M - Exercise X -500 96,500 -0.52
2015-05-22 2015-05-21 4 AAVL Avalanche Biotechnologies, Inc.
Common Stock
S - Sale X -500 7,000 -6.67 38.87 -19,435 272,090
2015-05-22 2015-05-21 4 AAVL Avalanche Biotechnologies, Inc.
Common Stock
M - Exercise X 500 7,500 7.14 2.75 1,375 20,625
2015-05-15 2015-05-14 4 [AAVL] Avalanche Biotechnologies, Inc.
Stock Option (Right to Buy)
M - Exercise X -500 97,000 -0.51
2015-05-15 2015-05-14 4 [AAVL] Avalanche Biotechnologies, Inc.
Common Stock
S - Sale X -500 7,000 -6.67 35.31 -17,656 247,188
2015-05-15 2015-05-14 4 [AAVL] Avalanche Biotechnologies, Inc.
Common Stock
M - Exercise X 500 7,500 7.14 2.75 1,375 20,625
2015-05-08 2015-05-07 4 AAVL Avalanche Biotechnologies, Inc.
Stock Option (Right to Buy)
M - Exercise X -500 97,500 -0.51
2015-05-08 2015-05-07 4 AAVL Avalanche Biotechnologies, Inc.
Common Stock
S - Sale X -500 7,000 -6.67 33.28 -16,638 232,934
2015-05-08 2015-05-07 4 AAVL Avalanche Biotechnologies, Inc.
Common Stock
M - Exercise X 500 7,500 7.14 2.75 1,375 20,625
2015-04-30 2015-04-28 4 AAVL Avalanche Biotechnologies, Inc.
Stock Option (Right to Buy)
M - Exercise X -1,000 98,000 -1.01
2015-04-30 2015-04-28 4 AAVL Avalanche Biotechnologies, Inc.
Common Stock
S - Sale X -1,000 7,000 -12.50 35.67 -35,667 249,669
2015-04-30 2015-04-28 4 AAVL Avalanche Biotechnologies, Inc.
Common Stock
M - Exercise X 1,000 8,000 14.29 2.75 2,750 22,000
2015-04-23 2015-04-21 4 AAVL Avalanche Biotechnologies, Inc.
Stock Option (Right to Buy)
A - Award 20,000 20,000
2015-04-23 2015-04-21 4 AAVL Avalanche Biotechnologies, Inc.
Stock Option (Right to Buy)
M - Exercise X -1,000 99,000 -1.00
2015-04-23 2015-04-21 4 AAVL Avalanche Biotechnologies, Inc.
Common Stock
A - Award 7,000 7,000
2015-04-23 2015-04-21 4 AAVL Avalanche Biotechnologies, Inc.
Common Stock
S - Sale X -1,000 0 -100.00 39.21 -39,211
2015-04-23 2015-04-21 4 AAVL Avalanche Biotechnologies, Inc.
Common Stock
M - Exercise X 1,000 1,000 2.75 2,750 2,750
2015-04-15 2015-04-14 4 AAVL Avalanche Biotechnologies, Inc.
Stock Option (Right to Buy)
M - Exercise X -1,000 100,000 -0.99
2015-04-15 2015-04-14 4 AAVL Avalanche Biotechnologies, Inc.
Common Stock
S - Sale X -1,000 0 -100.00 39.45 -39,448
2015-04-15 2015-04-14 4 AAVL Avalanche Biotechnologies, Inc.
Common Stock
M - Exercise X 1,000 1,000 2.75 2,750 2,750
2015-04-08 2015-04-07 4 AAVL Avalanche Biotechnologies, Inc.
Stock Option (Right to Buy)
M - Exercise X -9,000 101,000 -8.18
2015-04-08 2015-04-07 4 AAVL Avalanche Biotechnologies, Inc.
Common Stock
S - Sale X -292 0 -100.00 39.06 -11,406
2015-04-08 2015-04-07 4 AAVL Avalanche Biotechnologies, Inc.
Common Stock
S - Sale X -8,708 292 -96.76 38.59 -336,019 11,268
2015-04-08 2015-04-07 4 AAVL Avalanche Biotechnologies, Inc.
Common Stock
M - Exercise X 9,000 9,000 2.75 24,750 24,750
2014-08-01 2014-07-30 4 AAVL Avalanche Biotechnologies, Inc.
Stock Option (Right to Buy)
A - Award 70,000 70,000
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)